Revolutionizing Cocoa Production: California Cultured Achieves Milestone in Plant Cell Culture

California Cultured, a pioneering startup specializing in flavanol-rich cocoa production through plant cell culture, has marked a significant milestone with the successful operation of a 2,000-liter custom-built plastic bioreactor. This innovative approach promises to redefine the economic landscape of plant cell culture by significantly reducing both capital and operational expenses.

Transforming the Conversation Around Plant Cell Culture

“With the production costs and product quality soon to be revealed, we anticipate a shift in the narrative surrounding the capabilities of plant cell culture,” stated Steve Stearns, head of strategy and business development, in an interview with AgFunderNews.

Stearns believes that once products enter the market, consumers will quickly recognize the efficiency plant cell culture offers for deriving ingredients like cocoa. He highlighted a longstanding industry focus on proteins, suggesting that compounds like cocoa, which are in high demand, might be more aligned with this production method.

Innovative Production Techniques: Scaling Out Rather Than Up

Traditionally, companies engaged in plant cell culture have relied on expensive stainless steel fermentation tanks or single-use plastic bags, which are inadequate for large-scale production. In contrast, California Cultured employs proprietary rigid bioreactors that can be reused thousands of times, heralding a new era in cost-effective production.

“Our systems are designed for continuous operation with an innovative steam sterilization process, making cleaning simpler and significantly cutting down on labor costs,” Stearns explained.

The 2,000-liter production run marks a key achievement, demonstrating a production-scale system rather than a mere lab experiment. California Cultured has also secured partnerships with major players, including bakery ingredients and chocolate giant Puratos, which plans to release B2B products utilizing its flavanol-rich cocoa.

Strategic Partnerships and Market Potential

The startup has confirmed an offtake agreement with Japan’s largest chocolate company, Meiji, to explore a variety of chocolate and chocolate-like products using California Cultured’s ingredients. Stearns emphasized that the 2,000-liter bioreactor is intended for direct commercial production.

“We aim to expand through many affordable reactors rather than constructing large centralized plants,” he noted. The cost of a new reactor is around $3,000, vastly lower than the $500,000 to $1 million associated with stainless steel alternatives, enabling competitive pricing without hefty initial investments.

Reducing Capital and Operating Expenses

While some skeptics liken the company’s economics to traditional biopharmaceutical stainless steel fermentation, Stearns contends that their strategy effectively alters the financial equation.

“Our reactors are affordable, but the real game-changer is the automated control systems we’ve developed, which allows for the management of numerous reactors with minimal labor inputs,” he explained.

A Three-Pronged Differentiation Strategy

California Cultured’s approach hinges on three key differentiators:

• Carefully selected cell lines tailored for traits crucial in chocolate production, such as fat content, flavor precursors, and flavanol richness.
• Low-cost reactor architecture, ensuring affordability throughout the supply chain.
• Advanced automation and control software that promotes efficient operations with reduced manual labor.

The Bigger Picture: Addressing Chocolate’s Supply Crunch

Although cocoa prices have recently decreased after reaching record levels in 2024 due to poor harvests and disease outbreaks affecting West African supplies, Stearns warns of a looming supply crunch.

“Cocoa demand is on the rise, further complicated by unstable yields caused by climate change, disease, and aging farms,” he explained.

California Cultured proposes a solution: by growing cocoa cells in bioreactors, a stable, local, and less resource-intensive supply chain for chocolate ingredients can emerge, independent of agricultural constraints.

Health-Conscious Innovations

The firm’s products are self-affirmed GRAS (Generally Recognized as Safe) in the U.S., and a GRAS notice has been submitted to the FDA. Their inaugural product, branded as “cultured cocoa powder,” minimizes processing to maintain flavanol levels, utilizing drying methods without lead or cadmium contamination.

This product is designed as a health ingredient, intended for low inclusion rates to enhance the health benefits of chocolate without acting as a bulk cocoa substitute. Stearns emphasizes that it is meant to elevate the flavanol content in chocolate while reducing heavy metal exposure.

Understanding Plant Cell Culture

Plant cell culture differs significantly from traditional agriculture, as it does not rely on sunlight, water, or soil; instead, it focuses on cultivating plant cells in bioreactors optimized for rapid production of high-value compounds.

This technology, already successful in drug production (notably the breast cancer drug Taxol), is gaining traction in the nutraceutical sector as traditional botanical supply chains face increasing threats.

Key advantages of plant cell culture include:

• Consistent supply of botanicals, less susceptible to climate change and supply chain disruptions.
• Controlled production of plant compounds regardless of environmental factors.
• Sustainable use of resources, minimizing the need for extensive agricultural land and water.
• Potential for higher yields by precisely controlling the conditions that enhance bioactive compounds.

Looking Ahead

California Cultured is positioning itself as a frontrunner in the field of plant cell culture, proving that a sustainable and efficient future for cocoa production is possible. Their innovative techniques and strategic partnerships pave the way for a new era in chocolate manufacturing.

For further insights, watch our interview with California Cultured CEO Alan Perlstein at the 2025 SynBioBeta conference in San Jose.